jetOPTIMUS® DNA Transfection Reagent
Transient and stable gene expression from plasmid DNA transfection
Adherent hard-to-transfect mammalian cell:
|Number of transfections|
1.5 ml of jetOPTIMUS® transfection reagent is sufficient to perform 3 000 transfections in 24-well plates or 750 transfections in 6-well plates following the standard protocol
Store jetOPTIMUS® at 5 °C ± 3°C.
Ace your DNA transfection in the cell model you need!
As Transfection Experts, we know that it is essential for biologists to work with physiologically relevant cell models. For gene expression studies, transfection is the preferred technique to introduce a gene of interest in a given cell model, due to its cost-effectiveness and simplicity-of-use in comparison to physical techniques (e.g. micro-injection, electroporation).
Several types of cells (primary cells, stem cells or cancer cell lines) remain difficult to transfect with DNA for different reasons: slow-dividing rates, cell fragility and cellular defense mechanisms. To address the current limits of DNA transfection and complement our existing gene expression portfolio (jetPEI®, jetPRIME®, jetMESSENGER®), Polyplus-transfection® engineered an innovative delivery nanoparticle: jetOPTIMUS®.
jetOPTIMUS® is a powerful transfection reagent that improves cellular uptake and endosomal escape of DNA in adherent cells (even in hard-to-transfect cells) resulting in higher transfection efficiency. In order to work in relevant physiological conditions, transfection with jetOPTIMUS® requires a minimum DNA quantity and reagent volume to keep an excellent cell viability and morphology.
|Reference number||Reagent size||Buffer size|
|101000051||jetOPTIMUS® 0.1 mL||10 mL|
|101000025||jetOPTIMUS® 0.75 mL||2 x 60 mL|
|101000006||jetOPTIMUS® 1.5 mL||4 x 60 mL|
|201000001||x||jetOPTIMUS® Buffer 60 mL|
Optimized DNA transfection efficiency on hard-to-transfect cells
jetOPTIMUS® is an innovative cationic nanotechnology developed to improve DNA transfection efficiency in easy- and difficult-to-transfect cells used as in vitro cell culture models. Tested on various primary cells and cell lines, jetOPTIMUS® proved its superiority by reaching higher transfection efficiencies and gene expression than main competitors.
Fig. 1: jetOPTIMUS® outperforms its main competitor. Transfection efficiency was assessed by FACS analysis in various cell lines 24 h after transfection with a plasmid coding for a GFP protein in 24-well plates. Conditions were set up according to the manufacturer’s recommendations both for Lipofectamine® 3000 and for jetOPTIMUS®.
Advanced nanotechnology: Superior gene expression using less material!
jetOPTIMUS® has been developed to increase transfection efficiency into a wide range of cell types, while keeping the amount of DNA as low as possible, and reducing the volume of reagent required compared to main competitors. Consequently, scientists can increase the number of transfections and reduce the cost per reaction by up to seven-fold (table 1).
Table 1: Lower volume of jetOPTIMUS® is required compared to Lipofectamine® 3000 in 24-well plate.
Excellent cell viability and morphology
Reaching high transfection efficiencies is often at the expense of cellular integrity, with adverse effects on cell cycle, metabolism and signaling pathways. At Polyplus-transfection, we make no compromise on cell integrity: jetOPTIMUS® transfection reagent is gentle on cells, allowing generation of biologically relevant data from gene expression studies.
Fig. 2: Cells remains healthy and keep a good morphology 24h after transfection. Phase contrast microscopy of both MDCK and VERO cells 24 h after transfections with a plasmid coding for a GFP protein performed according to the manufacturer’s recommendations for each reagent.
Optimized transfection protocol
jetOPTIMUS® is a ready-to-use transfection reagent provided with its own complexation buffer (jetOPTIMUS® Buffer). The protocol is optimized for simplicity of use (all plate sizes), culture medium compatibility (antibiotics, serum) and cost-effectiveness (lowest amount of DNA and volume of reagent).
Fig. 3: Simplicity of the jetOPTIMUS® protocol for DNA transfection, here in 24-well plates.
Plasmids are small circular DNA molecules that are commonly found in bacteria. Plasmids exist and replicate separately from chromosomal DNA and in bacteria they often carry genes that are beneficial for bacterial survival. Plasmids can be deliberately introduced into desired cells and utilized to overexpress a gene of interest in a specific cell line. This procedure is called DNA transfection and is a commonly used method for studying gene function or protein of interest.
📰 Available Application Notes:
CRISPR genome editing
The use of the CRISPR/Cas9 system in mammalian cells has recently emerged as a very convenient way to modify the cell genome at a specific locus. It involves transient transfection into mammalian cells of either (a) one or several plasmids coding for Cas9, the specific gRNA and eventually the sequence to be inserted, or (b) a mix of one or two plasmids and an RNA molecule (the gRNA).
📰 Download our Researcher’s guide to Genome editing!
jetOPTIMUS® transfection reagent is highly effective for routine virus production of both AAV and lentivirus in adherent cells grown in classical media such as DMEM in presence of serum.
Each lot of jetOPTIMUS® is tested in-house by DNA transfection in HeLa cells following standard protocol. Every batch will be provided with Certificate of Analysis.
Polyplus-transfection® is ISO 9001 Quality Management System accredited since 2002; this level of certification assures global customers that the supplier has established reliable and effective processes for product development, manufacturing, sales and customer support.
In order to download a product protocol or a certificate of analysis, please create an account on Polyplus-transfection® Portal.
Why would you need to create an account?
In this personal area you will have access to:
- Product Protocols
- Certificates of Analysis
- Exclusive webinars/articles
- And surprise features!
Related blog posts
|Cell Line||in vitro|
|Delivered Molecule||Reagent||Results & Citations|
|Rat primary cardiomyocytes||in vitro||DNA||jetOPTIMUS|
Song N. et al. (2020)
Oxid Med Cell Longev ,
Heat Shock Protein 70 Protects the Heart from Ischemia/Reperfusion Injury through Inhibition of p38 MAPK Signaling
|4T1, ID8, MC-38||in vitro||DNA||jetOPTIMUS|
Mondal T. et al. (2021)
EMBO Mol Med ,
Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies
Naveh Tassa S. et al. (2021)
ACS Chem Neurosci 12(9), 1563-1577
A Mechanism for the Inhibition of Tau Neurotoxicity: Studies with Artificial Membranes, Isolated Mitochondria, and Intact Cells
|PC-12||in vitro||shRNA plasmid||jetOPTIMUS|
Wei X. et al. (2021)
J Neuroinflammation 18, 96
Inhibiting BDNF/TrkB receptor improves resiniferatoxin-induced postherpetic neuralgia through decreasing ASIC3 signaling in dorsal root ganglia
Zhang X. et al. (2021)
Pharmacol Res ,
hIgDFc-Ig inhibits B cell function by regulating the BCR-Syk-Btk-NF-κB signalling pathway in mice with collagen-induced arthritis
|HEK-293T, HeLa||in vitro||DNA||jetOPTIMUS|
Perez-Leal O. et al. (2021)
CRISPR J ,
Multiplex Gene Tagging with CRISPR-Cas9 for Live-Cell Microscopy and Application to Study the Role of SARS-CoV-2 Proteins in Autophagy, Mitochondrial Dynamics, and Cell Growth
|Human primary fibroblasts||in vitro||DNA||jetOPTIMUS|
von Elsner L. et al. (2021)
Biallelic FRA10AC1 variants cause a neurodevelopmental disorder with growth retardation
|HT22||in vitro||DNA, siRNA||INTERFERin, jetOPTIMUS|
Wang S. et al. (2021)
Front Genet 12, 615340
Functional Network of the Long Non-coding RNA Growth Arrest-Specific Transcript 5 and Its Interacting Proteins in Senescence
Van Zeebroeck L. et al. (2021)
Front Immunol 12, 655122
Fast and Efficient Genome Editing of Human FOXP3 + Regulatory T Cells
Wan JF. et al. (2022)
Acta Pharmacol Sin ,
Z16b, a natural compound from Ganoderma cochlear is a novel RyR2 stabilizer preventing catecholaminergic polymorphic ventricular tachycardia